Abstract:We read with great interest the well-written article by Wang and colleagues on the investigation of the prognostic value of nodal skip metastasis (NSM) in thoracic esophageal squamous cell carcinoma (ESCC) [1Wang F. Zheng Y. Wang Z. Zheng Q. Huang Q. Liu S. Nodal skip metastasis in esophageal squamous cell carcinoma patients undergoing three-field lymphadenectomy.Ann Thorac Surg. 2017; 104: 1187-1193Abstract Full Text Full Text PDF PubMed Scopus (20) Google Scholar]. They found that NSM had no effect on overall survival (OS), but only was associated with a relatively poor prognosis in individuals with solitary node metastasis. We congratulate Dr Wang and his colleagues for their innovative and excellent study. Intriguingly, we have also recently investigated the predictive ability of NSM in a large cohort of ESCC patients (n = 1,525) treated with surgery. Clinicopathological features of the 2 studies are comparable. Furthermore, both studies shared the same criteria to define the NSM according to the pN classification system of the Japan Esophageal Society (JES). Despite their homogeneity, the 2 studies had an opposite finding: On one hand, the NSM rate was remarkably higher in Wang and associates’ study (64%) as compared with the incidence observed in our cohort (24%); on the other hand, our study highlighted that patients with NSM had a significantly better OS compared with those without NSM, which was in accordance with its predictive role in lung cancer [2Legras A. Mordant P. Arame A. et al.Long-term survival of patients with pN2 lung cancer according to the pattern of lymphatic spread.Ann Thorac Surg. 2014; 97: 1156-1162Abstract Full Text Full Text PDF PubMed Scopus (50) Google Scholar]. It aroused our interest to explore the possible reason for the conflict conclusions. We noticed that Wang and colleagues used the former edition of the JES staging system for esophageal cancer (10th) to define the lymph node (LN) groupings, whereas the latest edition (11th) was applied in our study. The 11th edition was published in 2015, 8 years after the publication of the 10th edition in 2007 [3Japan Esophageal SocietyJapanese classification of esophageal cancer, 11th edition: part I.Esophagus. 2017; 14: 1-36Crossref PubMed Scopus (475) Google Scholar]. In the latest edition, the lymph node groupings were considerably updated in accordance with the new viewpoints of lymph node metastasis. Among these revisions, the scope of group-1 lymph node has been substantially extended. We propose that the expanded scope of group-1 LN does not only refer to the increased number of LN station, but also the addition of the LN that may function as a sentinel LN. Therefore, the NSM classified by the 11th edition is downsized, and may be more appropriate to stand for the phenomenon of skip metastasis. Thus, we are curious to know whether the prognostic role of NSM will be changed or not in Wang and colleagues’ cohort when using the pN classification of the 11th edition of JES. Nodal Skip Metastasis in Esophageal Squamous Cell Carcinoma Patients Undergoing Three-Field LymphadenectomyThe Annals of Thoracic SurgeryVol. 104Issue 4PreviewThe clinical and prognostic implications of nodal skip metastasis (NSM) remain unclear in patients with esophageal squamous cell carcinoma (ESCC). Full-Text PDF

Prognostic Significance of Solitary Lymph Node Metastasis in Patients with Squamous Cell Carcinoma of Middle Thoracic Esophagus

Investigation To Metastasis Of Regional Lymph Node Station And Prediction To Long-Term Survival Following Esophagectomy In Thoracic Esophageal Cancer With Stage T1 To T3.

Nodal Skip Metastasis is not a Predictor of Survival in Thoracic Esophageal Squamous Cell Carcinoma

Prognostic Significance of Preoperative Lymph Node Assessment for Patients with Stage Pn0 Esophageal Squamous Cell Carcinoma after Esophagectomy.

Clinical Analysis on Lymph Node Metastases of Thoracic Esophageal Squamous Cell Carcinoma

PROGNOSTIC EVALUATION OF NODAL SKIP METASTASIS FOR THORACIC ESOPHAGEAL SQUAMOUS CELL CARCINOMA

Prognostic Role of Nodal Skip Metastasis in Thoracic Esophageal Squamous Cell Carcinoma: A Large-Scale Multicenter Study

Survival Benefit of Skip Metastases in Surgically Resected N2 Non-Small Cell Lung Cancer: A Multicenter Observational Study of a Large Cohort of the Chinese Patients

Prognostic Value of Node Skip Metastasis on Esophageal Cancer: A Systematic Review and Meta-Analysis

555. SUPRACLAVICULAR NODE INVOLVEMENT, A NODAL OR METASTATIC DISEASE? - A 10-YEAR EXPERIENCE IN ESOPHAGEAL CARCINOMA AT A TERTIARY REFERRAL CENTRE

Effect of Cervical Paraesophageal Lymph Node Metastasis Versus Supraclavicular Lymph Node Metastasis on the Overall Survival of Patients with Thoracic Esophageal Squamous Cell Carcinoma: an Observational Study

Subcarinal Node Metastasis in Thoracic Esophageal Squamous Cell Carcinoma

Solitary Lymph Node Metastasis in Gastric Carcinoma

Prognostic Significance of Lymph Node Characteristics on Survival in Esophageal Squamous Cell Carcinomas

Clinicopathological Features of Lymph Node Metastasis and Prognostic Factors in Esophageal Cancer Treated with Minimally Invasive Esophagectomy

The Clinical Significance and Risk Factors of Solitary Lymph Node Metastasis in Gastric Cancer.

Nodal Skip Metastasis: A Promising Predictor of Prognosis in ESCC.

Prognostic Impact of Lymph Node Harvest for Patients with Node-Negative Esophageal Squamous Cell Carcinoma: a Large-Scale Multicenter Study

[Analysis of Lymph Node Metastasis in the Thoracic Esophageal Squamous Cell Carcinoma].

A Novel Multivariate Scoring System for Determining the Prognosis of Lymph Node-Negative Esophageal Squamous Cell Carcinoma Following Surgical Therapy: an Observational Study

Solitary Lymph Node Metastasis is a Distinct Subset of Colon Cancer Associated with Good Survival: a Retrospective Study of Surveillance, Epidemiology, and End-Results Population-Based Data